Quantcast

Latest Regulus Therapeutics Stories

2014-08-06 16:29:29

- 'Clinical Map Initiative' On Track; Human Proof of Concept Results for RG-101 and Nomination of Third Clinical Candidate Expected by YE 2014 - LA JOLLA, Calif., Aug.

2014-07-30 16:29:26

LA JOLLA, Calif., July 30, 2014 /PRNewswire/ -- Regulus Therapeutics Inc.

2014-07-16 08:27:14

CARLSBAD, Calif., July 16, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.

2014-06-25 08:30:45

- New Method of Use Claims Strengthen Patent Estate Covering microRNA-122 Inhibitors for the Treatment of HCV Infection - LA JOLLA, Calif., June 25, 2014 /PRNewswire/ --

2014-06-24 08:29:49

CARLSBAD, Calif., June 24, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.

2014-06-16 08:28:15

- Recognized Industry Leader Brings Extensive Clinical and Product Development Expertise - LA JOLLA, Calif., June 16, 2014 /PRNewswire/ --

2014-05-16 08:25:56

CARLSBAD, Calif., May 16, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.

2014-05-09 16:24:39

LA JOLLA, Calif., May 9, 2014 /PRNewswire/ -- Regulus Therapeutics Inc.

2014-05-08 16:27:14

- 'Clinical Map Initiative' On Track; Advanced RG-101 and RG-012, Expect to Nominate Third microRNA Clinical Candidate by YE 2014 - LA JOLLA, Calif., May 8, 2014 /PRNewswire/ --

2014-05-01 16:32:43

LA JOLLA, Calif., May 1, 2014 /PRNewswire/ -- Regulus Therapeutics Inc.


Word of the Day
logocentrism
  • The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.
The word 'logocentrism' is a blend of logo- +‎ centrism.
Related